This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
June 3, 2014 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that
William S. Marth, President and Chief Executive Officer at AMRI, will present at the 2014 Wells Fargo Healthcare Conference on
Tuesday, June 17, 2014 at
10:00 a.m. ET.
A webcast of the presentation can be accessed at the Investor Relations' section of
www.amriglobal.com, or at the following URL:
The webcast will be archived for 90 days following the live presentation.
About AMRI Albany Molecular Research Inc. (AMRI) is a global contract research and manufacturing organization that has been working with the Life Sciences industry to improve patient outcomes and the quality of life for more than two decades. With locations in
Asia, our key business units include Large Scale Manufacturing (LSM) and Discovery and Development Solutions (DDS). The LSM business unit includes API and Drug Product Manufacturing, which supports the commercial cGMP manufacturing of complex APIs, starting materials, clinical formulation development and aseptic fill and finish. Our DDS unit provides comprehensive services from hit identification to IND, including expertise with diverse chemistry, library design and synthesis,
in vitro biology and pharmacology, drug metabolism and pharmacokinetics, as well as natural products. For more information about AMRI, please visit our website at
www.amriglobal.com or follow us on Twitter (